Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
3159829
Reference Type
Journal Article
Subtype
Review
Title
Autoimmune diseases in HIV-infected patients: 52 cases and literature review
Author(s)
Iordache, L; Launay, O; Bouchaud, O; Jeantils, V; Goujard, C; Boue, F; Cacoub, P; Hanslik, T; Mahr, A; Lambotte, O; Fain, O; Associated authors
Year
2014
Is Peer Reviewed?
Yes
Journal
Autoimmunity Reviews
ISSN:
1568-9972
EISSN:
1873-0183
Volume
13
Issue
8
Page Numbers
850-857
Language
English
PMID
24747058
DOI
10.1016/j.autrev.2014.04.005
Abstract
OBJECTIVES:
1) To describe autoimmune diseases (AD) in HIV-infected people; and 2) to perform a literature review concerning this issue.
DESIGN:
52 HIV-infected patients that presented an AD in 14 medical departments in Paris and Ile-de-France area were retrospectively included in this study.
RESULTS:
The ADs were vasculitis (11), immune cytopenias (8), rheumatic diseases (8), lupus (7), sarcoidosis (7), thyroid diseases (6), hepatic diseases (5), and antiphospholipid syndrome (4). Four patients presented 2 ADs. In 5 patients the AD preceded HIV infection, in 14 HIV infection was diagnosed at the same time as the AD and 34 were HIV-infected when they developed an AD. 40 ADs (80%) occurred in patients with a CD4 T lymphocyte count of more than 200/mm(3). Cases of autoimmune hemolytic anemia occurred only in patients severely immunodepressed. In five patients (a vasculitis case, a sarcoidosis case, three thyroid disease cases) the AD presented as a form of immune restoration inflammatory syndrome (IRIS). Some ADs allowed HIV-infection diagnosis at a stage of moderate immune deficiency (vasculitis, antiphospholipid syndrome, immune thrombocytopenia). 37 patients received immunosuppressant treatments with good tolerance. These results confirm in a large series of patients previous data concerning autoimmune diseases occurrence in HIV-infected people.
CONCLUSION:
In the HAART era, when HIV-infected people are treated more and more early, autoimmune diseases can occur, mainly at the phase of immunological recovery. HIV infection should not limit immunosuppressant treatment use.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity